Home › Compare › OCTHF vs O

OCTHF vs O: Dividend Comparison 2026

OCTHF yields 71428.57% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OCTHF wins by $1.6804617092236922e+25M in total portfolio value
10 years
OCTHF
OCTHF
● Live price
71428.57%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.6804617092236922e+25M
Annual income
$16,758,464,082,723,930,000,000,000,000,000.00
Full OCTHF calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.18
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,098.20
Full O calculator →

Portfolio growth — OCTHF vs O

📍 OCTHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCTHFO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCTHF + O cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
OCTHF pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCTHF
Annual income on $10K today (after 15% tax)
$6,071,428.57/yr
After 10yr DRIP, annual income (after tax)
$14,244,694,470,315,339,000,000,000,000,000.00/yr
O
Annual income on $10K today (after 15% tax)
$448.90/yr
After 10yr DRIP, annual income (after tax)
$4,333.47/yr
At 15% tax rate, OCTHF beats the other by $14,244,694,470,315,339,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCTHF + O for your $10,000?

OCTHF: 50%O: 50%
100% O50/50100% OCTHF
Portfolio after 10yr
$8.402308546118461e+24M
Annual income
$8,379,232,041,361,964,000,000,000,000,000.00/yr
Blended yield
99.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

OCTHF
No analyst data
Altman Z
-28.5
Piotroski
3/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.6% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCTHF buys
0
O buys
0
No recent congressional trades found for OCTHF or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCTHFO
Forward yield71428.57% ✓5.28%
Annual dividend / share$2.00$3.23 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1% ✓
Portfolio after 10y$1.6804617092236922e+25M$34.2K ✓
Annual income after 10y$16,758,464,082,723,930,000,000,000,000,000.00 ✓$5,098.20
Total dividends collected$1.6801590475897682e+25M$20.7K ✓
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: OCTHF vs O ($10,000, DRIP)

YearOCTHF PortfolioOCTHF Income/yrO PortfolioO Income/yrGap
1← crossover$7,153,557$7,142,857.14$10,818$607.86+$7.14M → OCTHF
2$4,783,059,608$4,775,405,302.31$11,786$741.30+$4783.05M → OCTHF
3$2,989,196,089,253$2,984,078,215,471.53$12,944$910.50+$2989196.08M → OCTHF
4$1,746,108,740,720,723$1,742,910,300,905,223.00$14,343$1,127.28+$1746108740.71M → OCTHF
5$953,366,906,359,837,700$951,498,570,007,266,600.00$16,053$1,408.17+$953366906359.82M → OCTHF
6$486,546,837,026,708,500,000$485,526,734,436,903,500,000.00$18,167$1,776.65+$486546837026708.50M → OCTHF
7$232,096,820,383,666,640,000,000$231,576,215,268,048,070,000,000.00$20,815$2,266.60+$232096820383666624.00M → OCTHF
8$103,489,940,016,498,150,000,000,000$103,241,596,418,687,620,000,000,000.00$24,179$2,927.66+$103489940016498147328.00M → OCTHF
9$43,133,653,750,454,530,000,000,000,000$43,022,919,514,636,880,000,000,000,000.00$28,521$3,833.95+$4.313365375045453e+22M → OCTHF
10$16,804,617,092,236,920,000,000,000,000,000$16,758,464,082,723,930,000,000,000,000,000.00$34,218$5,098.20+$1.6804617092236922e+25M → OCTHF

OCTHF vs O: Complete Analysis 2026

OCTHF — Stock

Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate is OCT461201, a selective CB2 receptor agonist in solid oral dosage form that is in pre-clinical development for use in the treatment of IBS-associated visceral pain, as well as neuropathic pain conditions, including post herpetic neuralgia. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.

Full OCTHF Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this OCTHF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCTHF vs SCHDOCTHF vs JEPIOCTHF vs KOOCTHF vs MAINOCTHF vs STAGOCTHF vs ADCOCTHF vs NNNOCTHF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.